Long-Term Outcomes of Early Surgery Versus Conventional Treatment for Asymptomatic Severe Mitral Regurgitation: A Propensity Analysis

S Sung-Ji Park (Division of Cardiology, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, South Korea) M Mijin Kim (Department of Physics and Chemistry) J Jihee Son H Ha Hye Jo G Ga Yun Kim (Division of Cardiology, Asan Medical Center, College of Medicine, University of Ulsan, Seoul, South Korea) J Jihoon Kim B Byung Joo Sun (Division of Cardiology, Asan Medical Center, College of Medicine, University of Ulsan, Seoul, South Korea) E Eun-Kyung Kim S Sahmin Lee (Division of Cardiology, Asan Medical Center, College of Medicine, University of Ulsan, Seoul, South Korea) J Jae Suk Yoo S Sung-Cheol Yun (Department of Biostatistics, Asan Medical Center, College of Medicine, University of Ulsan, Seoul, South Korea) S Sung-Ho Jung (Department of Thoracic and Cardiovascular Surgery, Asan Medical Center, College of Medicine, University of Ulsan, Seoul, South Korea) J Jong-Min Song (Division of Cardiology, Asan Medical Center, College of Medicine, University of Ulsan, Seoul, South Korea) D Duk-Hyun Kang (Division of Cardiology, Asan Medical Center, College of Medicine, University of Ulsan, Seoul, South Korea)

Abstract

BACKGROUND: The timing of surgery in asymptomatic severe mitral regurgitation remains controversial. This observational study sought to compare long-term outcomes of early surgery with a conventional treatment strategy in asymptomatic patients with severe mitral regurgitation. METHODS: From 1996 to 2016, a total of 1063 consecutive asymptomatic patients (673 men; mean±SD age, 51±14 years) with severe degenerative mitral regurgitation and preserved left ventricular function were enrolled, and followed prospectively for a median of 12 years (interquartile range, 8–17 years). Early surgery was performed on 545 patients and the conventional treatment strategy was chosen for 518 patients. We compared overall and cardiac mortality rates between these 2 treatment strategies using propensity score adjustment. RESULTS: In the early surgery group, no operative deaths occurred, and mitral valve repair was successfully performed in 97% of patients. During follow-up, 8 (1.5%) patients in the early surgery group and 54 (10.4%) in the conventional management group died from cardiovascular causes (hazard ratio, 0.17 [95% CI, 0.07–0.40]; P <0.001). A total of 74 (13.6%) deaths from any cause occurred in the early surgery group, whereas 116 (22.4%) occurred in the conventional management group (hazard ratio, 0.72 [95% CI, 0.52–0.99]; P =0.046). For the 358 propensity score matched pairs, the early surgery group had a significantly lower risk of cardiac mortality than the conventional treatment group (hazard ratio, 0.18 [95% CI, 0.08–0.43]; P <0.001) and significantly lower cardiac mortality rates (5.6% versus 17.4% at 20 years; P =0.002). Compared with the conventional treatment group, the early surgery group also had a significantly lower risk of overall mortality (hazard ratio, 0.66 [95% CI, 0.47–0.93]; P =0.018) and significantly lower overall mortality rates (28.2% versus 33.9% at 20 years; P =0.015). CONCLUSIONS: Compared with conventional management, early surgery is associated with better long-term outcomes among asymptomatic patients with severe mitral regurgitation and preserved left ventricular function. REGISTRATION: URL: https://www.clinicaltrials.gov ; Unique identifier: NCT01703806.

Article Details

Journal Circulation
Volume / Issue Vol. 152, Issue 17
Published October 28, 2025
Pages 1209-1217
ISSN 0009-7322
Publisher Lippincott Williams & Wilkins

Journal Info

Circulation

Lippincott Williams & Wilkins

ISSN: 0009-7322 Health Sciences

Authors (14)

S

Sung-Ji Park

Division of Cardiology, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, South Korea

M

Mijin Kim

Department of Physics and Chemistry

J

Jihee Son

H

Ha Hye Jo

G

Ga Yun Kim

Division of Cardiology, Asan Medical Center, College of Medicine, University of Ulsan, Seoul, South Korea

J

Jihoon Kim

B

Byung Joo Sun

Division of Cardiology, Asan Medical Center, College of Medicine, University of Ulsan, Seoul, South Korea

E

Eun-Kyung Kim

S

Sahmin Lee

Division of Cardiology, Asan Medical Center, College of Medicine, University of Ulsan, Seoul, South Korea

J

Jae Suk Yoo

S

Sung-Cheol Yun

Department of Biostatistics, Asan Medical Center, College of Medicine, University of Ulsan, Seoul, South Korea

S

Sung-Ho Jung

Department of Thoracic and Cardiovascular Surgery, Asan Medical Center, College of Medicine, University of Ulsan, Seoul, South Korea

J

Jong-Min Song

Division of Cardiology, Asan Medical Center, College of Medicine, University of Ulsan, Seoul, South Korea

D

Duk-Hyun Kang

Division of Cardiology, Asan Medical Center, College of Medicine, University of Ulsan, Seoul, South Korea